Sharing of clinical trial data among trialists: a cross sectional survey

Objective To investigate clinical trialists’ opinions and experiences of sharing of clinical trial data with investigators who are not directly collaborating with the research team. Design and setting Cross sectional, web based survey. Participants Clinical trialists who were corresponding authors of clinical trials published in 2010 or 2011 in one of six general medical journals with the highest impact factor in 2011. Main outcome measures Support for and prevalence of data sharing through data repositories and in response to individual requests, concerns with data sharing through repositories, and reasons for granting or denying requests. Results Of 683 potential respondents, 317 completed the survey (response rate 46%). In principle, 236 (74%) thought that sharing de-identified data through data repositories should be required, and 229 (72%) thought that investigators should be required to share de-identified data in response to individual requests. In practice, only 56 (18%) indicated that they were required by the trial funder to deposit the trial data in a repository; of these 32 (57%) had done so. In all, 149 respondents (47%) had received an individual request to share their clinical trial data; of these, 115 (77%) had granted and 56 (38%) had denied at least one request. Respondents’ most common concerns about data sharing were related to appropriate data use, investigator or funder interests, and protection of research subjects. Conclusions We found strong support for sharing clinical trial data among corresponding authors of recently published trials in high impact general medical journals who responded to our survey, including a willingness to share data, although several practical concerns were identified.

[1]  J. Conley Asking questions: A practical guide to questionnaire design , 1983 .

[2]  Floyd J. Fowler,et al.  Survey Research Methods , 1984 .

[3]  J. Kirwan,et al.  Making original data from clinical studies available for alternative analysis. , 1997, The Journal of rheumatology.

[4]  D A Asch,et al.  Response rates to mail surveys published in medical journals. , 1997, Journal of clinical epidemiology.

[5]  Melissa S. Anderson,et al.  Withholding research results in academic life science. Evidence from a national survey of faculty. , 1997, JAMA.

[6]  P. Allotey,et al.  Data sharing in medical research: an empirical investigation. , 2001, Bioethics.

[7]  S. Hilgartner,et al.  Data withholding in academic genetics: evidence from a national survey. , 2002, JAMA.

[8]  A. Hrõbjartsson,et al.  Constraints on publication rights in industry-initiated clinical trials. , 2006, JAMA.

[9]  Stephen Hilgartner,et al.  Data Withholding in Genetics and the Other Life Sciences: Prevalences and Predictors , 2006, Academic medicine : journal of the Association of American Medical Colleges.

[10]  A. Vickers Whose data set is it anyway? Sharing raw data from randomized trials , 2006, Trials.

[11]  Asbjørn Hróbjartsson,et al.  Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors , 2006, Clinical trials.

[12]  S. Goodman,et al.  Reproducible Research: Moving toward Research the Public Can Really Trust , 2007, Annals of Internal Medicine.

[13]  Heather A. Piwowar,et al.  Sharing Detailed Research Data Is Associated with Increased Citation Rate , 2007, PloS one.

[14]  Heather A. Piwowar,et al.  Towards a Data Sharing Culture: Recommendations for Leadership from Academic Health Centers , 2008, PLoS medicine.

[15]  D. Altman,et al.  Towards agreement on best practice for publishing raw clinical trial data , 2009, Trials.

[16]  A. Vickers,et al.  Empirical Study of Data Sharing by Authors Publishing in PLoS Journals , 2009, PloS one.

[17]  S. Keyhani,et al.  Doctors on coverage--physicians' views on a new public insurance option and Medicare expansion. , 2009, The New England journal of medicine.

[18]  D. Altman,et al.  Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers , 2010, BMJ : British Medical Journal.

[19]  F. Godlee,et al.  Missing clinical trial data: setting the record straight , 2010, BMJ : British Medical Journal.

[20]  Trish Groves,et al.  BMJ policy on data sharing , 2010, BMJ : British Medical Journal.

[21]  J. Grimshaw,et al.  Five years of Trials , 2011, Trials.

[22]  P. Gøtzsche,et al.  Access to data in industry-sponsored trials , 2011, The Lancet.

[23]  J. Ioannidis,et al.  Public Availability of Published Research Data in High-Impact Journals , 2011, PloS one.

[24]  P. Gøtzsche,et al.  Opening up data at the European Medicines Agency , 2011, BMJ : British Medical Journal.

[25]  Mark Walport,et al.  Sharing research data to improve public health , 2011, The Lancet.

[26]  B. Wieseler,et al.  Still waiting for functional EU Clinical Trials Register , 2011, BMJ : British Medical Journal.

[27]  Sunila R. Kalkar,et al.  Investigator experiences with financial conflicts of interest in clinical trials , 2011, Trials.

[28]  Access to clinical trial data , 2011, BMJ : British Medical Journal.

[29]  Peter C Gøtzsche,et al.  Why we need easy access to all data from all clinical trials and how to accomplish it , 2011, Trials.

[30]  Harlan M Krumholz,et al.  A model for dissemination and independent analysis of industry data. , 2011, JAMA.

[31]  P. Gøtzsche,et al.  Sponsors’ participation in conduct and reporting of industry trials: a descriptive study , 2012, Trials.

[32]  T. Hampton European drug agency works to improve transparency, but skepticism remains. , 2012, JAMA.

[33]  H. Krumholz Documenting the methods history: would it improve the interpretability of studies? , 2012, Circulation. Cardiovascular quality and outcomes.

[34]  J. Sloan,et al.  Burnout and satisfaction with work-life balance among US physicians relative to the general US population. , 2012, Archives of internal medicine.

[35]  Harlan M Krumholz,et al.  Open science and data sharing in clinical research: basing informed decisions on the totality of the evidence. , 2012, Circulation. Cardiovascular quality and outcomes.

[36]  Cary P Gross,et al.  The importance of clinical trial data sharing: toward more open science. , 2012, Circulation. Cardiovascular quality and outcomes.

[37]  C. Gross,et al.  Promoting transparency in pharmaceutical industry-sponsored research. , 2012, American journal of public health.

[38]  M. Rodwin,et al.  Clinical trial data as a public good. , 2012, JAMA.